Brief: Editas Medicine And Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

Editas Medicine

01/05/2024 13:37

May 1 (Reuters) - Bristol-Myers Squibb Co  BMY.N :
    * EDITAS MEDICINE AND BRISTOL MYERS SQUIBB EXTEND ALPHA-BETA
T
CELL COLLABORATION
    * EDITAS MEDICINE INC: UNDER COLLABORATION, BRISTOL MYERS
SQUIBB
HAS OPTED INTO 13 DIFFERENT PROGRAMS ACROSS 11 GENE TARGETS TO
DATE
    * EDITAS:2 YEAR EXTENSION COLLABORATION WITH BRISTOL
MYERS,PARTIES
MAY RESEARCH, DEVELOP,COMMERCIALIZE AUTOLOGOUS, ALLOGENEIC
ALPHA-BETA T CELL MEDICINES
    * EDITAS MEDICINE INC: EXTENSION ALSO HAS OPTIONS TO EXTEND
COLLABORATION FOR UP TO AN ADDITIONAL TWO YEAR

Source text for Eikon:  ID:nGNX44QYXc 
Further company coverage:  BMY.N 

 ((Reuters.Briefs@thomsonreuters.com))